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The significance of bats as sources of emerging infectious diseases has been increasingly appreciated, and new
data have been accumulated rapidly during recent years. For some emerging pathogens the bat origin has been
confirmed (such as lyssaviruses, henipaviruses, coronaviruses), for other it has been suggested (filoviruses).
Several recently identified viruses remain to be ‘orphan’ but have a potential for further emergence (such as
Tioman, Menangle, and Pulau viruses). In the present review we summarize information on major bat-
associated emerging infections and discuss specific characteristics of bats as carriers of pathogens (from
evolutionary, ecological, and immunological positions). We also discuss drivers and forces of an infectious
disease emergence and describe various existing and potential approaches for control and prevention of such
infections at individual, populational, and societal levels.
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I
nfectious diseases continue to emerge and the ma-
jority of these are zoonotic in origin (1, 2). Zoonotic
infections, particularly those caused by RNAviruses,
have been recognized as a significant human health
threat, particularly in developing countries (3). The
significance of bats as reservoirs of such emerging
infectious diseases (EIDs) has been increasingly appre-
ciated (4). New pathogens are documented in bats every
year and most of these new agents still require character-
ization. The majority of studies performed to date have
focused on infections of significant public health and
veterinary concern. In this paper, we summarize the
available information on several selected pathogens,
including lyssaviruses, coronaviruses, henipaviruses, and
filoviruses, for which a considerable amount of informa-
tion has been collected to date on a global basis (Fig. 1).
Bat rabies*a global threat
Rabies is an acute progressive encephalitis caused by
viruses in the Genus Lyssavirus, Family Rhabdoviridae,
with the highest fatality rate among conventional in-
fectious diseases. Known in bats for well over a century,
rabies is the best studied infection associated with the
Chiroptera. Bats are the principal reservoirs for 10 of the
11 recognized lyssavirus species and are suspected as
hosts of other putative species (5). Only one lyssavirus,
Mokolavirus (MOKV), has never been isolated from bats
to date. However, the principal reservoir for MOKV is
unknown (6). Another viral species, rabies virus (RABV),
circulates in bats and other mammals (predominantly
carnivores). Interestingly, RABV circulates in bats only in
the Americas, whereas in carnivores, the disease circulates
globally. In the Old World, bats maintain circulation of
other lyssavirus species, such as Lagos bat virus (LBV),
Duvenhage virus (DUVV), European bat lyssaviruses
type 1 (EBLV-1) and 2 (EBLV-2), Australian bat lyssa-
virus (ABLV), Aravan virus (ARAV), Khujand virus
(KHUV), Irkut virus (IRKV), West Caucasian bat virus
(WCBV), and Shimoni bat virus (SHIBV). For these
viruses, bats are the principal hosts, with only a few
spillover infections documented in other mammals. Iso-
lation of RABV from Eurasian bats has been suggested
several times, but never confirmed (reviewed in Kuzmin
and Rupprecht (7)). Indeed, the surveillance data from
developing countries is very limited. We do not know
which lyssaviruses circulate in bats of northern Africa
and southern Asia, although historical reports (8, 9)
along with more recent serological findings (10 12)
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A paralytic disease in cattle and sporadically in
humans bitten by a vampire bat has been reported from
the time of the Spanish first colonized Latin America.
However, the diagnosis of rabies was first confirmed by
the identification of Negri bodies in the brain of cattle
during an outbreak in Brazil in 1911 (13). Vampire bats
probably maintained rabies virus circulation for a long
time prior to the arrival of Europeans in the Americas.
The association between vampire bites and the disease
was understood by natives, who cauterized or washed the
bites to prevent the disease (14). However, historical
antecedents might be some other progenitor virus, quite
different from those ones that circulate in bat populations
presently.
Economic losses due to vampire bat rabies in livestock
are tremendous. In the enzootic area there is an at-risk
population of more than 70 million head of cattle.
Vampire bats usually bite many animals in a herd. The
proportion of animals bitten may vary from 6 to 52%
(15). Significant outbreaks of vampire bat rabies were
documented in Amazon area (Brazil, Peru) during recent
years. Up to 23 55% of respondents interviewed had
vampire bat bites during the last year. During the
outbreaks, up to 15% of such bites caused rabies in
humans (reviewed in Kuzmin and Rupprecht (7)).
An idea that vampire bats may be asymptomatic rabies
carriers, shedding the virus in their saliva for months, was
popular during initial studies of vampire bat rabies (16).
However, in a well-documented experimental study by
Moreno and Baer (17), the disease in vampire bats was
similar to rabies observed in other mammals. The bats
that developed signs of disease and excreted the virus via
saliva soon died, whereas those that survived the
inoculation without clinical signs never excreted the virus
or had it in the brain as demonstrated upon euthanasia.
More recently, the asymptomatic excretion of RABV in
the saliva of experimentally infected vampire bats, which
survived the challenge during at least 2 years of observa-
tion, was documented again (18). Clearly, this phenom-
enon requires additional investigation.
Rabies of insectivorous bats was first documented in
1953 in Florida. Later it was documented across the
United States, in Canada, and Latin America. Several
RABV lineages were documented, and in general, they
correspond to particular host species (reviewed in Kuz-
min and Rupprecht (7)). Moreover, widely distributed
bat species, such as Mexican free-tailed bat (Tadarida
brasiliensis) and big brown bat (Eptesicus fuscus), main-
tain circulation of several RABV variants across their
geographic range. Insectivorous bats are the major source
of human rabies in the United States and Canada, which
became especially prominent after elimination of RABV
circulation among dogs. During 1958 2009, a total of 49
naturally acquired human rabies cases caused by bat
RABV variants were reported in the United States and
Canada (excluding four rabies cases caused by organ
transplantation from a donor who died of unrecognized
rabies) (19,20). In 19 of these cases the exposure was
‘cryptic’, as the patients did not recall any contact with
animals or a bat was seen flying in the residence but no
direct physical contact was reported. Appears that some
bat bites, especially if they were inflicted by small bat
species, may be ignored or not recognized as dangerous
Fig. 1. Bat-associated and presumable bat-associated EIDs. Abbreviations: RABV, rabies virus; EBLV-1,2 European bat
lyssaviruses type 1 and 2; WCBV West Caucasian bat virus; ARAV Aravan virus; KHUV Khujand virus; IRKV Irkut virus;
LBV Lagos bat virus; SHIBV Shimoni bat virus; DUVV Duvenhage virus; MARV Marburg virus; EBOV Ebola virus;
Filovirus unclassiﬁed ﬁlovirus detected in bats in Europe; HeV Hendra virus; NiV Nipah virus; Henipavirus unclassiﬁed
henipavirus; SARS-CoV SARS coronavirus.
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mentally disabled, or intoxicated person).
Two closely related RABV variants (previously con-
sidered as one), associated with the silver-haired bat
(Lasionycteris noctivagans) and eastern tri-colored bat
(Perimyotis subflavus) have caused about 60% of human
rabies cases, where the virus variant could be identified.
These bats are relatively small, do not form large
colonies, and usually do not roost in close proximity to
human dwellings. In contrast, the big brown bat RABV
variant and the Myotis RABV variant caused one human
case each, even if these bats frequently occupy house
attics and crevices in men-made constructions. Further-
more, big brown bats constitute about 90% of all rabid
bats, submitted to diagnostic laboratories in the United
States and definitely have more contacts with humans
(21,22). The Mexican free-tailed bat RABV variant
caused several human rabies cases as well, including
four cases that occurred in 2004 after transplantation of
organs and vessel from a donor who died of rabies (23).
Several versions were suggested to explain the dispropor-
tional prevalence of the silver-haired bat and eastern tri-
colored bat RABV variant among human rabies cases.
Investigations suggested that these viruses have enhanced
pathogenicity to humans, for example they may have a
greater ability to replicate in fibroblasts and epithelial
cells, being delivered into a superficial bat bite (24).
In the Old World, the significance of bat rabies for
veterinary and public health is well addressed only in the
countries with developed surveillance systems, such as
Western Europe and Australia. The EBLV-1 and EBLV-2
circulate in Europe among insectivorous bats Eptesicus
fuscus and Myotis spp, respectively. These viruses caused
at least three cases of human rabies, where the virus was
characterized, in Finland, Russia, and in the UK
(reviewed in Kuzmin and Rupprecht (7)). The IRKV,
first identified in insectivorous bat Murina leucogaster in
eastern Siberia during 2002 (25), was known by this only
one isolate until 2007, when it caused a human death
after a bite of unidentified insectivorous bat in the
Russian Far East (26). Moreover, at least three other
cases, where the viruses were not identified but the disease
was compatible with rabies and developed after bat
exposure, were reported from the Ukraine and China
(27 29). A few cases of spillover EBLV-1 infections were
documented in terrestrial mammals, including domestic
cats (30), and they represent a potential exposure risk for
humans.
The EBLVs, as well as IRKV, are covered by the
commercially available rabies biologics (31,32), therefore
the disease can be efficiently prevented by administration
of standard rabies post-exposure prophylaxis (PEP). This
is not the case for WCBV. This virus, isolated from
insectivorous bat Miniopterus schreibersii in south-eastern
Europe, is the most divergent member of the Lyssavirus
genus, and rabies biologics are incapable of providing
significant protection against it (32). Because of lacking
surveillance, there is only one isolate of WCBV available
to date. Ecology of this virus and its significance for
public health are unknown. However, laboratory animals
and bats, infected with WCBV, developed typical rabies
and died (33).
A variety of bat lyssaviruses have been documented in
Africa. The LBV, first documented in Nigeria in 1956
(34), was further isolated in many sub-Saharan countries
(35). Moreover, in 1999 it was imported into France with
fruit bats Rousettus aegyptiacus captured in Togo or
Egypt (36). Fruit bats of several species serve as reservoir
hosts for LBV, with infrequent spillover infections
documented in dogs, cats, and a mongoose (37). The
viruses, currently included into LBV, represent several
divergent lineages and there is a possibility that further
taxonomic efforts may facilitate separation of these
viruses into two or three species (5,38,39). Another
divergent lyssavirus, SHIBV, was isolated from insecti-
vorous bat Hipposideros commersoni in Kenya in 2009.
The SHIBV demonstrates similarity to MOKV and LBV,
but cannot be included into any of these species (5).
Significance of these viruses for public health is unknown
however, as in the case of WCBV, they are pathogenic for
laboratory animals, which develop rabies and die after
intracranial or peripheral inoculation (5,35,40). Further-
more, due to their antigenic differences, they are not
covered by current rabies biologics (32,41).
Recently, serologic reactivity to WCBV was detected in
Miniopterus bats of several species from Kenya (42).
Given that WCBV does not cross-react serologically with
other known lyssaviruses, this seroprevalence indicates
that WCBV or some other antigenically similar virus
circulates in Africa as well (and probably more broadly,
corresponding to the distribution range of Miniopterus
bats).
Another African bat lyssavirus, DUVV, is covered by
rabies biologics, but still kills people because of insuffi-
cient knowledge, either in general public and health
professionals. The DUVV is perhaps the most mysterious
African lyssavirus. Of four isolates available, three came
from humans who died of rabies after bat exposures and
only one was isolated from an insectivorous bat, pre-
sumptive Miniopterus sp (43). The most recent human
case occurred in 2007 in Kenya, where a Dutch tourist
was attacked by a bat in a campsite of Tsavo West
national park. The patient applied for medical help, but a
local physician assured that bat rabies does not exist in
Kenya and PEP was not administered. Several weeks
later, back in the Netherlands, the patient developed
rabies and died. The virus was identified as DUVV (44).
The discovery of ABLV in 1996 in the ‘rabies-free’
Australia was surprising. Following the discovery that
flying foxes were a reservoir of Hendra virus, surveillance
Bats and emerging infectious diseases
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ABLV was identified first in a sick black flying fox
(Pteropus alecto). The second case was diagnosed retro-
spectively in another bat of the same species, sampled in
1995 with signs of unusual aggressiveness (45). Later
ABLV was documented in each of the four flying fox
species, present in continental Australia. Furthermore, a
genetically divergent variant of ABLV was discovered in
insectivorous bats Saccolaimus flaviventris (46).
Two human cases of ABLV infection have been
documented to date. Both were fatal and clinical
symptoms were compatible with rabies. The first one
was reported very shortly after the virus discovery in
1996. The patient was a 39-year-old female presumably
infected by a S. flaviventris bat in her care. The virus that
was isolated was compatible with this bat species (46,47).
The second case occurred in a 37-year-old female who
developed rabies in 1998, approximately 27 months after
presumable exposure from a bite by an unspecified flying
fox. This isolate belonged to the pteropid ABLV variant
(48,49).
Filoviruses in bats
Filoviruses, such as Lake Victoria Marburg virus
(MARV) and Ebola virus (EBOV), cause severe hemor-
rhagic fever with a high fatality case rate in humans (80 
90%). Furthermore, they are easily transmitted between
humans, and several significant outbreaks were reported
from sub-Saharan Africa (50 52). The index cases of
MARV infection occurred during 1967 among laboratory
workers in Germany and the former Yugoslavia, who
handled tissues and blood of African non-human pri-
mates (53). However, the natural reservoirs of filoviruses
have been unknown for many years, in spite of significant
international efforts to determine their natural relation-
ships. Until recently, these viruses were identified only in
moribund humans and apes. The situation changed
between 2001 and 2005, when antibodies to EBOV were
detected in four species of tree-roosting fruit bats from
Gabon: 4 of 17 Hypsignathus monstrosus, 8 of 117
Epomops franqueti, and 4 of 58 Myoncteris torquata.
Viral RNA was detected in the liver and spleen of other
bats from the same populations: 4 of 21, 5 of 117, and 4
of 141, respectively (50). However, no direct link between
human disease and bat exposure could be established.
More recently, an epidemiologic investigation putatively
linked the index case of EBOV outbreak in the Demo-
cratic Republic of the Congo (DRC) in 2007 to a contact
with freshly killed fruit bats, which were migrating in
close proximity to the outbreak villages and represented
an important food source for local people (54).
Furthermore, retrospective analysis demonstrated that
the majority of human cases of MARV infection could be
linked to visitation of caves and mines. Recently, it was re-
iterated by fatal cases of MARV infection in tourists who
visited caves in Uganda where multiple bats were present
(55,56). Surveillance of a variety of animals, collected in
the Durba mine (DRC) during the MARV outbreak,
demonstrated the presence of MARV RNA in insectivor-
ous bats from the Rhinolophus and Miniopterus genera
and in Egyptian fruit bats (Rousettus aegyptiacus), but
not in animals from many other taxa including verte-
brates and invertebrates (51). Similarly, MARV RNAwas
detected in R. aegyptiacus from Gabon, Uganda, and
Kenya, whereas in other bat species it was detected only
occasionally. Moreover, in Uganda, infectious virus was
isolated from R. aegyptiacus with a high RNA load
detected by the polymerase chain reaction (PCR). Gene
sequences of MARV strains identified in bats were
identical to those in humans (52,57,58).
However, the detailed ecology of filoviruses is still
unknown. Reports on seroprevalence in bats are some-
what controversial. Colonies of R. aegyptiacus in caves
often consist of tens of thousands of bats (Fig. 2). The
opportunity for conspecific exposure rates in such
colonies appears quite high and, therefore, bat popula-
tions should have a significant seroprevalence rate to
these viruses. For example, seroprevalence to lyssaviruses
in some colonial bat species was reported as high as 60 
70% (35). In contrast, the seroprevalence of MARV
neutralizing antibodies in colonies of R. aegyptiacus
where PCR-positive bats were collected was only approxi-
mately 12% or as low as 2.4% (52,57). It is still unclear
whether bats are the principal reservoir hosts of filo-
viruses, or if they represent a spillover infection from
some other source. In fact, the identity of gene sequences
from bat and human isolates does not necessarily mean
that humans were infected from bats. Potentially, bats
and humans could be independently and simultaneously
infected from some other source in mines and caves.
Fig. 2. A dense colony of the Egyptian fruit bats (Rousettus
aegyptiacus) in cave (Photo by Ivan V. Kuzmin).
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spillover into humans is limited. Nevertheless, as trans-
mission mechanisms and the sources of such spillover
infections are poorly understood, public awareness must
be increased, and health authorities informed about the
documented and suspected presence of filoviruses in bats.
Enhanced ecological and epidemiological study of wild-
life, such as bats and their associated pathogens, will
assist in the eventual prevention and control of these
highly pathogenic EIDs.
Henipaviruses and other paramyxoviruses: a
recent emergence with severe consequences
In 1994, at the Brisbane suburb of Hendra, Australia,
infection with a previously undescribed member of the
Paramyxoviridae family caused the deaths of 13 horses
and one human from an acute respiratory disease (59,60).
The virus, known initially as equine morbillivirus, was
later renamed Hendra virus (HeV). Thereafter, in 1995, a
farmer from Mackay, in Queensland, developed fatal
HeV encephalitis, attributed to exposure to two HeV-
infected horses that had died more than a year ago
(61,62). The HeV outbreak stimulated enhanced surveil-
lance to find the natural reservoir of the virus. Fruit bats
(Pteropus spp.) were found to have a high seroprevalence
to HeV, indicating that they may be a wildlife reservoir.
Serological evidence of HeV infection has not been found
in any animal species, other than bats in the Pteropus (so-
called flying foxes) genus (63,64). As was demonstrated
experimentally, Pteropus bats develop subclinical infec-
tion after inoculation with HeV with transient viremia
(65,66).
Another related paramyxovirus, Nipah virus (NiV),
was first recognized in a large human outbreak that
affected 283 persons and caused 109 deaths in Malaysia
during 1999. The outbreak was preceded by a large NiV
outbreak among pigs, which resulted in a culling of over a
million swine (67,68). Genetic similarity between NiVand
HeV suggested creation of the Henipavirus genus within
the viral family Paramyxoviridae (69) and a search of NiV
reservoir among fruit bats. Antibodies against NiV virus
were identified in two native Pteropus species in Malaysia
(70). The virus was subsequently isolated from urine
samples from a P. hypomelanus colony on Tioman Island
(71). The initial porcine outbreak was thought to be
caused by transmission of NiV from fruit bats to pigs.
One of the scenarios suggested that an infected fruit bat
might drop a piece of contaminated fruit within a pig sty
or, alternatively, an infected sick or dead bat might be
eaten by pigs.
Further antibodies to NiV were detected in Pteropus
bats from Cambodia, Thailand, China, and Bangladesh
(72 75). In Bangladesh, several severe outbreaks of NiV
encephalitis in humans were documented starting from
the early 2000s, with case fatality rates about 70 90%. In
a few initial outbreaks, contacts with sick livestock were
suggested as a source of the infection, whereas for other
outbreaks direct transmission of NiV from Pteropus
giganteus bats to index cases was suggested via consump-
tion of contaminated fruits or drinking of contaminated
date palm sap with further human-to-human transmis-
sion (74,76,77).
In 2001, an outbreak of febrile illness in humans,
associated with an altered sensorium, was observed in
Siliguri, India. Laboratory investigations at the time of
the outbreak did not identify an infectious agent. Because
Siliguri is in close proximity to Bangladesh, where
outbreaks of NiV infection were recently described,
clinical material obtained during the Siliguri outbreak
was retrospectively analyzed for evidence of viral infec-
tion. The presence of NiV antibodies and RNA were
detected in  50% of the patients. As in Bangladesh,
direct human-to-human transmission was observed be-
tween family members of the patients and hospital staff
(78).
The distribution of Pteropus bats is limited to islands
of the Pacific and Indian Oceans and continental areas
from Pakistan east across Southeast Asia to Australasia.
By inference, this area might be considered enzootic for
henipavirus distribution. However, recent discoveries
changed this interpretation. Antibodies to NiV were
detected in several fruit bat species in Madagascar
including Pteropus rufus, Eidolon dupreanum, and Rou-
settus madagascariensis. The two latter species are not
members of Pteropus genus and their exposure to NiV
might occur via contact with P. rufus (79). However, later
seroprevalence to henipaviruses was detected in 22 39%
of Eidolon helvum fruit bats from Ghana, out of the
Pteropus genus range (80). Moreover, divergent henipa-
virus RNA was detected in fecal samples of these bats.
One of the obtained gene sequences was most related to
NiV and another two represented novel genetic lineages
within the Henipavirus genus (81). This is remarkable
because E. helvum is highly abundant in sub-Saharan
Africa and form large colonies, which conduct annual
transcontinental migration following the rainfall gradient
to suitable feeding grounds (82). These animals fre-
quently roost in urban settings and, in several African
countries, are routinely hunted and consumed by humans
as a supplementary source of protein.
During the search for NiV on the Tioman Island, two
other bat viruses were isolated in addition to the NiV,
which was the main target. These were Tioman virus and
Pulau virus (83,84). Tioman virus was a novel paramyx-
ovirus in the genus Rubulavirus, whereas Pulau virus was
a novel reovirus in the genus Orthoreovirus. At the time of
discovery, both viruses were orphans in terms of their
significance for veterinary and public health.
In 1997, during the investigation of a swine disease
outbreak a new paramyoxvirus, named Menangle virus,
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large commercial piggery in New South Wales, Australia
(85). Serological investigation of persons in contact with
pigs revealed that two humans, who were in close contact
with infected pigs and suffered an influenza-like illness,
had high levels of neutralizing antibodies to Menangle
virus (86). Antibodies to Menangle virus were detected in
all four species of flying foxes in Australia (87).
Molecular and antigenic studies indicated that Tioman
virus is very closely related to Menangle virus, which
indirectly confirmed the bat origin of Menangle virus
(83,88). The potential of Tioman virus to infect and cause
disease in human or other animals is unknown. However,
recent studies have demonstrated that pigs are susceptible
for infection by Tioman virus (89) and that there is
serological evidence for infection of humans by this virus
on Tioman Island (90).
SARS-like and other coronaviruses in bats
Severe acute respiratory syndrome (SARS) emerged
during November 2002 in southern China, and a SARS
coronavirus (SARS-CoV) was identified as the etiologic
agent (91). This epidemic, and the identification of
SARS-CoV in animals, associated with the wildlife trade
in southern China particularly in civets and raccoon dogs
(92) stimulated increased CoV surveillance. As demon-
strated from the outbreak, none of the suspect animals
were a direct source of SARS-CoV. Furthermore, sur-
veillance led to identification of SARS-like CoVs in
horseshoe bats (Rhinolophus spp) in China. These CoVs
shared similar genomic organization and identity with
SARS-CoV, except for the spike protein gene S, which is
responsible for binding to the receptor on susceptible cell
surface (93,94). The level of nucleic acid sequence
difference ( 8%) from SARS CoV in multiple genes
was too great for SARS-like CoV in Rhinolophus bats to
be the parent to the outbreak virus. The presence of
multiple SARS CoV-like viruses, the inability to detect
SARS CoV-like viruses in other species of wild animals,
and the detection of a wide range of other coronaviruses
in bats suggests that bats are a rich source of CoVs,
however, the evolutionary pathway of SARS-CoV re-
mains to be fully identified.
Further surveillance and characterization of bat CoVs
identified close members of many known mammalian
CoV species as well as several species exclusively present
in the bat. These studies revealed high genetic diversity
bat CoVs across a large geographic distribution. More-
over, the same species of bat from different geographic
locations can also contain the same type of CoV (95). In
China, high CoV prevalence was detected in the Vesper-
tilionidae and Rhinolopidae families of bats. The overall
prevalence was about 6%, but in certain bat colonies it
was as high as 35 55%. Such diversity was significant and
not only SARS-like CoVs (from Betacoronavirus, former
group 2) but also additional putative novel subgroups
from Alphacoronavirus (former group 1) were identified in
bats (96). Similar results were reported from Hong Kong
(97). Further studies demonstrated that CoV-positive
bats appeared healthy, with only a limited reduction of
body weight, with viral clearance occurring between 2
weeks and 4 months (98). In addition, the authors
reported that co-infection of the same bat species by
two different coronaviruses, a SARSr-Rh-BatCoV Rp3
from Guangxi, China, and a Rf1 from Hubei, China,
may have allowed the opportunities for recombination via
a breakpoint at the nsp16/spike region and possibly
generated a recombinant virus*the Civet SARSr-CoV.
After the discovery of SARS-like CoVs in bats in Asia,
a number of bat CoVs were identified in Europe, North
America, South America, Australia, and Africa with an
overall prevalence of 9 to 20%. In Europe, the alphacor-
onaviruses and betacoronaviruses, identified in Vesperti-
lionidae bats, were genetically similar to the CoVs
identified in bats from China (99). In the United States,
17% of Eptesicus fuscus and 50% of Myotis occultus were
positive for CoVs. Phylogenetically these viruses belonged
to the same alphacoronavirus group but formed distinct
clusters from Asian CoVs (100). In Canada, an alphacor-
onavirus identified in Myotis lucifugus bat is probably
a variant of alphacoronaviruses identified in Myotis
occultus in the United States. In South America, the
Trinidadain CoVs identified in Phyllostomidae bats were
clustered with alphacoronavirus from North America. In
Africa, enhanced surveillance demonstrated significant
divergence of CoVs in bats from Kenya (101). In that
study, SARS-like CoV was identified in a Chaerephon sp.
bat (Molossidae). Furthermore, in contrast to China and
Hong Kong, various CoVs were detected in bats from the
families Hipposideridae and Pteropidae. Overall CoV
prevalence in Kenya bats was approximately 19%, and
CoV diversity was greater compared to that documented
in Asia, Europe, North and South Americas, and
Australia.
In general, the diversity of CoVs in bats appears
greater than in other animals tested to date. This
observation suggests that bats are likely the primary
hosts of this viral family. Because attempts to isolate
CoVs from bats by multiple international groups have
failed and only viral RNA was detected (predominantly
in fecal swabs), this limitation significantly reduces the
possibility to investigate CoV pathobiology, evolution,
and adaptive mechanisms in vitro and in vivo.
Bats: are they special?
Why are bats the reservoirs of so many EIDs? Bats have
several unique features that may account for their
importance in EID transmission and maintenance. Bats
are the second largest order of mammals. Currently, there
are  1,200 recognized bat species worldwide, accounting
Ivan V. Kuzmin et al.
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The diversity of bat species alone, along with their
worldwide distribution, contributes to the biodiversity
of their pathogens.
Bats are unique in their mobility as they are the only
mammals capable of flight, allowing them to transmit
EIDs during their foraging flights and during seasonal
migrations. This extensive mobility, coupled with roosting
plasticity and broad food range, means that bats could
transport viral material to many different animal species
in various locations per unit time (103).
The ability to fly also has immunological implications.
Flight requires a low body mass and bats have evolved to
have hollow bones to decrease their body mass. The
hollow bones allow them to fly, but as a result they do not
have bone marrow as similar to non-volant mammals and
must produce B-cells in different locations (104). Whereas
basic immunological commonalities are shared among all
mammals, certain unique anatomical and physiological
parameters peculiar to bats may also help to explain the
plethora of agents associated with this mammalian order.
Besides their ecological vagility, bats are considered
one of the most social groups of mammals (Fig. 2). Many
bat species roost together in very large and dense
colonies. This dense clustering of individuals provides
ample opportunities for viral exchange within bat popu-
lations (103). Bats with high levels of interspecies contact,
such as Myotis, have been found to harbor a diverse
range of RABV, suggesting that increased contact
between species increases viral transmission (105). Sev-
eral infectious agents, including NiV, have been isolated
from the urine of fruit bats and during mutual grooming
fur contaminated by urine may allow for viral transmis-
sion between individuals (68,106).
Regarding ecological flexibility, bats inhabit a wide
variety of ecological niches. Some species are flexible in
roost preferences, including caves, trees, and many man-
made structures, other are more restricted to specific
roosting. The ability of bats to occupy men-made
structures is of particular importance, because it increases
the opportunities for interactions between bats, domestic
animals, and humans. For example, the big brown
bat (Eptesicus fuscus) and the serotine bat (Eptesicus
serotinus), both of which are known to harbor lyssa-
viruses, commonly roost in men-made structures. Bats
often inhabit and feed in agricultural areas, which brings
them into closer contact with humans and domesticated
animals. In the tropics, frugivorous bats can be found
roosting urbanistically and feeding on fruit trees in
plantations (107).
Not only are bats able to inhabit a variety of diverse
locations, but they also have a number of trophic
specializations. The majority of bat species are frugivor-
ous or insectivorous. In addition, three bat species, all
found in Central and South America, are hematophagous
(vampire bats). These dietary habits affect rabies trans-
mission risks as described above. Depletion of environ-
mental resources and urban expansion into bat habitats
can deplete natural food sources. When their natural food
sources are scarce, vampire bats will switch preferences
and feed on humans and domestic animals (14). Frugi-
vorous bats often leave behind half-eaten fruits that may
be contaminated with viral particles from their saliva; if
the viral levels are high enough, an animal may develop
infection following consumption of these fruits. It is
hypothesized that the consumption of half-eaten fruits
may have caused the transmission of NiV from fruit bats
to pigs and humans, as well as sharing of the raw date
palm sap from the tree collectors (67,68,76,77). Similarly,
insectivorous bats will discard contaminated insect parts,
which can then be consumed by foraging animals (107),
although mechanisms for such route of pathogen trans-
mission from insectivorous bats has not been corrobo-
rated to date. Omnivorous bats, such as Phyllostomidae,
will consume nectar, plants, arthropods, and small
vertebrates as food sources as necessary. This ability to
utilize a wide variety of food sources may lead to
increased biodiversity in a small area, enhancing the
opportunities for multiple species to interact and share
infectious pathogens. Environmental factors can shape
pathogen transmission and spillover into a new species as
well; periods of resource limitation may bring together
diverse species. During the dry season, primates and bats
may come into closer contact as they search for limited
food supplies, enhancing opportunities for cross-species
transmission of filoviruses (107).
Although their mobility, sociality, and ability to inhabit
a variety of niches likely influence the importance of bats
as sources of EIDs, there are some additional character-
istics of bats that may contribute into this phenomenon.
For example, Microchiroptera possess the ability to
echolocate, to produce laryngeal vocalizations for naviga-
tional purposes. Echolocation may cause aerosolization
of viral particles in the nasal mucosa and saliva,
enhancing transmission to other individuals (4). How-
ever, this mode of transmission has not been experimen-
tally verified to date. Additionally, when adjusted for
body mass, Chiroptera are the longest-living mammalian
order (108). Although long-term viral persistence in bats
remains to be determined, a long-lived carrier would have
even more opportunities to transmit the infection within
bats populations and to other species.
The long evolutionary history of bats may also play a
role in their association with EIDs, because of long co-
evolution between bats and the viruses. Pathogens could
have evolved to utilize cellular receptors that are con-
served across a wide range of animal species, providing a
mechanism for interspecific infections (4,109). For ex-
ample, henipaviruses are capable of infecting species in
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receptor that is conserved among animals (109).
The specific immunological parameters that are in-
volved in agent evolution leading to persistence or
perpetuation of EIDs in bat populations are not fully
understood. Recent studies have examined innate, anti-
viral, and interferon genes from several species of bat,
and suggest that certain alleles may be associated with
increased parasite burden (110). Cells expressing surface
immunoglobulin were identified in Pteropus indicating
that lymphoid development in bats, as well as immune
system components, like IgG, IgM, IgA, macrophages, B-
and T-lymphocyte-like cells, are similar to other mam-
mals (111,112). In studies examining leukocyte response
to the phytohemagglutinin (PHA) skin test, a technique
used to measure delayed-type cellular immune response
in many vertebrates, diverse leukocyte traffic was ob-
served in the 6 24 hours following PHA injection (113).
Bat interferon alpha and beta are homologous to other
mammalian interferons, but there is low homology of
these interferons specifically between bats and humans,
which could indicate different antiviral activity between
the two and contribute to the high pathogenicity of bat
agents in humans (114).
In addition, recent sequencing of genome fragments to
infer genes within the interferon alpha family in both
Pteropus and Myotis bats has revealed that both have up
to 24 IFNW genes, while humans, mice, and pigs have
only one (115). The enormous size of this gene family
within bats compared to other mammals suggests that it
may still be involved in host immune defense, even
though its function may have been lost in other verte-
brates. He et al. (116) suggested that the bat interferon
alpha gene family is under positive selection, which most
likely reflects an evolutionary arms race, between patho-
gens evolving to block immune recognition and host
immune systems responding to maintain effective re-
sponse to these pathogens. However, based on latitude,
some bats undergo hibernation during winter, which has
been shown to decrease levels of neutrophils, monophils,
and lymphocytes, leading to immunosuppression in other
small mammals (117). If so, how do related infectious
agents overwinter in bats? These and many other ques-
tions about basic bat immunology and pathobiology of
bat-adapted pathogens still remain unanswered. Serolo-
gical assays have shown though that some virus specific
adaptive T- and B-cell responses do occur, despite the
suggestion of persistent infection with viruses including
HeV, SARSs-CoV, and EBOV (reviewed in Calisher et al.
(4)). In addition, bats are capable of harboring large
numbers of genetically diverse viruses within a geographic
location and within a taxonomic group (118). Several
viruses for which bats act as a reservoir, including the
paramyxo-, filo-, and rhabdoviruses, appear phylogeneti-
cally related and grouped in the order Mononegavirales,
possibly indicating a more fundamental connection
between bats and these specific RNA agents (119).
Persistence or perpetuation of bat-associated
EIDs
The essential pathobiology of bat agents contributes
inherently to their persistence or perpetuation in reservoir
individuals, colonies, and populations. Based on current
research, there is very little evidence to suggest that any of
the major bat-associated EIDs persist within the host,
and it is therefore most likely that these viruses are
maintained in nature by perpetuation within and between
bat colonies and through multiple spillover events into
other hosts due to the extreme mobility and highly social
nature of the bat hosts. Among these various agents,
lyssaviruses have been most thoroughly characterized.
For example, RABV, the representative species of this
genus, perpetuates through bite transmission between
infected animals. In essence, RABV is characterized by a
rather low basic reproductive rate and a short infectious
period. Bats mount both an innate and adaptive immune
response to peripheral RABV infection. Helper and
cytotoxic T-cells activate upon infection, to recognize
and clear the virus both outside and inside of infected
cells. However, once the virus reaches the CNS, the host
adaptive immune response is less able to clear infection.
Pathogenic RABV may limit its replication rate and
produce fewer infectious particles to completely evade, or
only minimally activate, the peripheral host response.
Single exposures do not always confer protection against
successive infections, leading to perpetuation in bat
populations, but repeated exposure has been shown to
provide long-term immunity (up to a year) and reduced
susceptibility (120). These findings have been corrobo-
rated by other studies that show that colony-wide
mortality does not increase significantly after episodes
of infection with EBLV-1 (121).
In affected bat colonies, a relatively low point pre-
valence of rabies infection has been usually observed,
varying from B1 to 4%. In contrast, prevalence levels of
RABV-neutralizing antibodies have been documented
between 65 and70% (reviewed in Kuzmin and Rupprecht
(7)). In bats, cave colonies show strong seasonal fluctua-
tions with increased seroprevalence in adult females and
juveniles directly following parturition (122). These
seasonal shifts may be due to the birth pulse, adding
large numbers of susceptible juveniles into the population
and increased contact rates between adult females and
pups while nursing. Recently, employing a model that
integrated immunological parameters, epizootiology,
and disease demography, Dimitrov et al. (123) showed
that total colony immunity is actually strengthened by
perpetuating RABV infection. This model predicted that
low removal rates of infected individuals (due to death)
led to a colony with a stronger total immune profile while
Ivan V. Kuzmin et al.
8
(page number not for citation purpose)
Citation: Emerging Health Threats Journal 2011, 4: 7159 - DOI: 10.3402/ehtj.v4i0.7159high removal rates, like that seen in other carnivores, led
to the epizootics normally associated with RABV.
Little is known about how NiV and HeV are main-
tained in bat populations. These viruses encode V
proteins that bind to signal transducer and activators of
transcription 1 (STAT1) and STAT2 proteins of host cells
to block alpha, beta, and gamma interferon responses
(124 126). Such V proteins may facilitate evasion of the
host immune system, although it is not well known how
viral proteins will affect potential interferon responses to
virus infections in bats. The NiV V protein can prevent
IFN signaling in cells from multiple species and other
proteins may also have specific activities (126). The
presence of multiple anti-IFN mechanisms may relate
to the zoonotic nature of henipaviruses but this remains
to be explored in Pteropodid bats, which are seemingly
natural reservoir of these viruses have likely passed a
long-term co-evolution.
Ecological studies suggest that NiV spillover events
may fluctuate seasonally. All outbreaks, with the excep-
tion of the initial spillover event in Malaysia, occurred
during the first 5 months of the year (74 78). Wachar-
apluesadee et al. (127) found that this time period
coincided with the time in which the greatest amount of
viral RNA could be recovered from wild populations of
Pteropus lylei. Horizontal transmission via urine, feces,
and saliva is thought to be the primary route of intra-
specific and spillover infection for HeV (128,129). Spil-
lover events of HeV into horses are associated with the
flying fox birthing season, when pregnant and lactating
females are at a higher risk for HeV infection (reviewed in
Halpin et al. (130)). These events are hypothesized to
occur through contact with either infected birthing
material or exposure to an increased number of infected
individuals. Models of HeV infection dynamics suggest
that the pathogen is not endemic in local populations, but
persists broadly due to meta-population dynamics.
Further, it has also been hypothesized that immunity in
Pteropus scapulatus, the principal reservoir of HeV, wanes
over short time scales and this could enhance the
persistence of infection in P. scapulatus populations.
Nutritional stress in response to decreases in fruit and
nectar availability has also been associated with increas-
ing risk of transmission (128,129).
In fact, bats were not the direct origin of the human
SARS epidemic but the diversity of bat coronaviruses is
fascinating. Modes of perpetuation of CoVs have not
been established, but an increase in prevalence within
lactating adult female bats has been demonstrated for
several vespertilionid species (99). As has been recently
shown, bats experimentally infected with CoV did not
develop clinical signs of disease, although viral RNA was
detected in their intestines and feces. In addition, reduced
susceptibility of bats to a CoV isolated from another bat
species has been demonstrated, suggesting that certain
CoV variants are well adapted to certain host species
(131).
Although both EBOV and MARV are hypothesized to
have a bat reservoir, no conclusive evidence has been
obtained to date. Though it is not known if or how EBOV
persists in bat populations, trends in great ape mortality
suggest the seasonal component. Death rates of great
apes have been observed to increase at the end of the
rainy season, which may lead to increased contact rates
between apes and other animals, including bats, compet-
ing for food (132 134). However, contacts between bats
and apes have also been observed during the dry season
when fruit is abundant and many animals share the same
food source locations (50,135).
Making ourselves sick: drivers of
bat-associated EIDs
As with other zoonotic EIDs, emergence of diseases from
bat reservoirs is primarily associated with ecological
changes that influence the host or parasite. More
specifically, changes that increase the duration or fre-
quency of host-pathogen interaction give rise to greater
opportunities for transmission (119). The underlying
causes of bat EIDs can be organized in a hierarchical
fashion (Fig. 3) as macro-scale societal changes lead to
increased animal/human interactions, which in turn lead
to increased disease emergence. Bat-associated EIDs
appear as a ‘tip of the iceberg’ regarding a much more
dynamic complex of interacting variables.
The pathways of disease transmission between bats,
peridomestic/domestic animals, and humans are sum-
marized in Fig. 4. Although we are predominantly
concerned with human pathogens, it should be noted
that infectious diseases emergence also occurs in non-
human hosts, including bats themselves, as a result of
ecological changes brought by human activity. For
example, the recent epizootic of White Nose Syndrome
(WNS) among several bat species in the Northeastern
United States may be due to the translocation of a fungus
from Europe to North America by humans (136).
Furthermore, it is highly probable that the emergence
of pathogens in bats also occurs via contact with
domestic/peridomestic animals. However, evidence in
support of this pathway is limited due to of lack of
research in this area.
The primary drivers of bat-associated EIDs include
overpopulation, environmental degradation, and socio-
economical forces. The emergence of new pathogens is
associated with growth and increased density of humans
and other mammals. In recent history, the human
population has exploded, with an increase from 1 billion
to 6.8 billion in the past 110 years. As populations grow,
humans begin to inhabit previously untouched, often
biodiverse areas. Research suggests that diseases are more
likely to emerge in such regions (2). Coupled with this is
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human demand for food and support consumption of
goods.
Environmental degradation causes habitat disturbance
and reduction, resulting in changes in species range and
density. For example, land use changes such as mining
and deforestation for farming and the construction of
human habitats in the Amazon Basin have likely con-
tributed to the re-emergence of vampire bat-derived
rabies in humans. In 2004, at least 46 deaths were caused
by vampire bat rabies (predominantly in Brazil and
Colombia), whereas only 20 cases were transmitted by
dogs in all of Latin America (137,138).
Economic forces unquestionably fuel environmental
destruction. Much of the deforestation and habitat
intrusion in the Amazon, for example, is a result of the
increasing demand for oil and minerals. Moreover,
economic forces contribute to secondary drivers such as
increased transportation, agricultural practices, food
availability, and choice regarding food consumption.
Socioeconomic inequalities, meanwhile, perpetuate
disease transmission through disparities in health care
Fig. 3. Diagram of primary and secondary drivers and management of bat-associated EIDs.
Fig. 4. Possible routes of disease transmission between bats, peridomestic/domestic animals, and humans. Thick arrows represent the
most signiﬁcant pathways for bat-associated EIDs. Thin arrows represent pathways about which less known or that are less common (as
in the case of transmission of pathogens directly from bats to humans).
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water. In addition, the increase in human population
density and mobility, together with environmental de-
struction and economic forces, are also contributing to
pathogen emergence. These primary drivers not only
contribute to risk by increasing the abundance of human
hosts, but also fuel more immediate causes of disease
emergence such as those discussed below.
Economic prosperity has led to advances in technol-
ogy, which has fostered the development of an expansive
global trade network. Increased mobility of people,
animals, and goods allows for the rapid spread of novel
diseases and outbreaks of existing diseases. The cross-
continental spread of infectious disease is most likely to
occur through air travel (139), while local transportation
networks may be important for sustaining epidemics
within continents (140). For example, the SARS outbreak
was first reported in Guandong, China in November of
2002 and within months a cluster of cases appeared in
Hong Kong (141). Due to air transit, SARS cases were
reported as far away as Canada (in addition to several
Southeast Asian countries) by the end of March of 2003
(142). As previously mentioned, the spread of WNS
throughout bat populations may serve as an example of
how human movement also influences the emergence of
EIDs in wildlife (136).
Large societal changes have led to smaller, more
regional phenomena that increase the emergence of
infectious diseases. For example, ecotourism likely in-
creases the rate of disease exposure through the direct
intrusion of humans into wildlife habitats (such as recent
cases of MARV infection in tourists after visitation of
caves in Africa (55,56), or DUVV infection of a tourist
bitten by a bat during a safari trip (44)).
Human practices surrounding the production and
consumption of food can contribute significantly to the
risk of new pathogen emergence. For example, wet
markets (in which live animals are sold and butchered
on the spot) are an ideal environment for microbial
exchange due to the high density of people, and the
diversity of wild and farmed animals sold at these sites.
Live animal markets appear to have contributed to the
emergence of SARS in China in 2002. With primary bat
origin, several intermediate hosts have been suggested
(such as Chinese ferret-badgers, Melogale moschata, and
raccoon-dogs, Nyctereutes procyonoides), although palm
civets (Paguma larvata) are suspected to be the most
important for the transmission of the virus to humans
(92). In Southern China, civets are both hunted and
farmed for eating. In fact, civets tested in wet markets
have a higher rate of seropositivity for SARS than those
tested on farms, suggesting that the markets may serve as
centers for viral transmission (143). In addition, food
handlers and persons employed at wet markets are more
likely to be seropositive than those with other occupa-
tions (144).
Consumption of bush meat is known to amplify the
risk of pathogen emergence and this is also true for the
transmission of bat-associated EIDs. Epidemiological
evidence suggests the direct transmission of EBOV from
bats to humans in the Democratic Republic of Congo,
where the migratory fruit bats, Hypsignathus monstrosus
and Epomops franqueti, are hunted and sold in markets
for consumption (54). Additionally, Eidolon helvum fruit
bats, a natural reservoir for LBV and henipaviruses, are
consumed in several regions of West Africa (80).
Furthermore, agribusiness has overshadowed small-
scale farming across the globe, particularly in Southeast
Asia. Industrialized agriculture involves the mass-pro-
duction of a single species of animal or plant. Mono-
culture increases susceptibility to pathogens due to the
widespread availability of hosts of the same species. This
is exemplified by the NiV outbreaks in Malaysia during
1998 1999. Deforestation and the increased farming of
pigs and fruit-producing trees are suspected to have
contributed to the swine infection with NiV. Of course,
the intensification and expansion of agriculture is a
serious concern throughout the world, as it is a driver
of many other EIDs (not associated with bats), the most
notorious of which are the avian influenza viruses.
Ironically, the achievements of human civilizations
over the past century have been the indirect drivers of
new classes of zoonotic diseases. These issues are not only
difficult to solve, but they are also expensive and
politically unpopular to address, as human economic
progress is often in inherent conflict with environmental
conservation.
Pathogen emergence occurs as a result of complex
interactions of many factors, requiring a multidisciplin-
ary approach to research and prevention. The drivers of
disease emergence are studied by professionals trained in
fields as diverse as disease ecology, anthropology, geo-
graphy, economics, wildlife population biology, and
wildlife veterinary medicine (1 3). A better understand-
ing of drivers of EID emergence is essential to inform
effective policies that address both the immediate and
underlying causes of disease emergence.
Control and prevention of bat-associated EIDs
The previous section focused on the mechanisms that
drive disease emergence from bats, progressing from
primary to more proximate factors. This section will
examine control in the opposite direction, progressing
from the individual level, proceeding through popula-
tion-wide approaches, and ending with society-wide
suggestions for primary prevention of bat-associated
EIDs.
Bats and emerging infectious diseases
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No specific medical therapy has proven beneficial once
people become ill from bat EIDs (at least of viral origin).
For example, although rabies is an ancient disease,
effective therapeutic treatment of rabies in humans
continues to be very challenging. Rapid early diagnosis
in the biting animal is critical, since identification of
rabies before its fulminant stage allows for effective
prophylaxis. Fulminant rabies continues to carry a very
poor prognosis. The first case of the successful experi-
mental treatment of rabies in a naı ¨ve patient was a 15-
year-old girl bitten by a bat in 2004 (145). However,
extension of the ‘Milwaukee Protocol’ (i.e., therapeutic
coma, antiviral drugs, intensive medical care) in other
patients has been much less successful (see for example
Rupprecht (146) and Rubin et al. (147)).
Prophylaxis, after exposure but well in advance of
illness, has a much higher success rate. Appropriate post-
exposure wound cleansing has been shown to reduce
significantly the likelihood of RABV transmission (148).
Besides washing the wound with soap and water, un-
vaccinated persons should receive both rabies immune
globulin and four doses of cell-culture vaccine. Globally,
more than 12 million persons receive post-exposure
prophylaxis each year (149).
Besides rabies, novel treatment strategies are being
developed for other bat EIDs. The use of RNA inter-
ference has been suggested for the treatment of henipa-
viruses (150). These currently untreatable infections may
be ameliorated by the introduction of small interfering
RNA molecules homologous to the RNA in these
pathogens. While promising in theory for many agents,
this line of treatment is still in its preliminary stages, and
issues such as efficacy in humans, delivery, and cost have
yet to be addressed.
The potential for filoviruses to be used as bioweapons
has spurred research efforts for an effective vaccine that
could be used in an outbreak. For example, in a mouse
model of hemorrhagic EBOV infection, a vesicular
stomatitis virus-based vaccine has been shown to be
safe and effective in preventing clinical presentation of
disease (151). Furthermore, the possibility that this
vaccine may be deliverable through mucosal surfaces
offers potential as a rapid vaccination agent during an
outbreak.
At the population level
At the population level, rabies is the quintessential bat
EID that has been studied most intensively. Public health
guidelines recommend rabies vaccination for humans in
high-risk groups, vaccination of pets as well as animals
on public display, isolation of domestic animals from the
wildlife reservoirs of rabies, and public health education
on appropriate precautions. Current guidelines recom-
mend that pre-exposure prophylaxis be offered to those in
high-risk groups including veterinarians, animal hand-
lers, rabies researchers, and some laboratory workers. In
addition, the vaccine can be offered to long-term travelers
to endemic areas, especially if immediate medical atten-
tion will be unavailable (148,152). Routine vaccination of
the general population is currently not recommended,
mostly due to cost.
Despite advances in determining best practices for
animal vaccination, control of rabies in domestic and
wild reservoirs remains challenging in resource-limited
settings. Control of rabies in bats has proven challenging.
Bat rabies has been reported in every state except Hawaii
and 1,806 rabid bats were documented in the United
States during 2009 (19). Of all animals, bats in particular
pose a serious risk for rabies and should be excluded from
structures to prevent contact with humans (148,152).
However, widespread reductions in bat populations to
control rabies is neither feasible nor desirable. Instead,
some novel methods have been explored to control
infection in bat populations. Vampire bats can efficiently
digest only coagulated blood and they die if the
consumed blood is not coagulated. Application of antic-
oagulant-containing ointment on the fur of captured
vampire bats (with their subsequent release) leads to
consumption of the coagulant by several roost mates via
mutual grooming. Similarly, anticoagulation of livestock
is another useful approach to control vampire bat
populations where rabies is a threat (reviewed in Kuzmin
and Rupprecht (7)). As another approach, it has been
suggested that oral vaccination of wildlife may limit the
spread of rabies by bats (153). Finally, we know that
some species of moths are able to disrupt bat echoloca-
tion using ultrasonic clicks of their own (154,155). The
use of similar, artificially produced, sounds to ward off
bats from human and livestock habitats should be
explored.
At the societal level
The recent emergence of SARS coronavirus and Henipa-
virus from bat reservoirs has spurred thinking on how to
control future disease emergence. As we noted in the
previous section, the primary drivers of emergence are
growing global mobility, environmental degradation, and
overpopulation.
We may be able to confront the threat presented by
increased global mobility with practical measures such as
transportation surveillance. Monitoring ports and bor-
ders for ill passengers and animals and providing care to
them would not only benefit the ill, but also the
populations they are moving into. Likewise, pre-trip
vaccinations and post-trip health monitoring not only
benefit the international travelers but also the population
to which they return.
Environmental conservation has long been the domain
of those hoping to preserve biodiversity and the magnifi-
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that environmental degradation leads to increased rates
of disease emergence, it may be time for those in the
public health field to also advocate environmental con-
servation. Since the effects of environmental degradation
on disease emergence are still not fully understood,
increased funding of research in this field is also sorely
needed.
Conclusions
The international attention to newly emerged or discov-
ered bat-associated EIDs has increased dramatically
during recent decades. The above brief review of recent
history highlights that pathogen discovery has been
accomplished in very different scenarios, from accidental
detection of ‘orphan’ viruses to the confirmation of bat
origin of known diseases using targeted surveillance.
Moreover, although this brief review has focused upon
the relationship of bats and emerging viruses, a number
of other diverse agents are also associated with bats
including bacteria such as Bartonella (156), and long-
standing relationships with certain fungal diseases such
as histoplasmosis (157). It is anticipated that, with the
advance of modern molecular tools and increased
scientific activities in this field, additional bat EIDs
with public health, veterinary, and conservation implica-
tions will be uncovered and better understood with
practical effective prevention and control modalities
necessary for application in the near future.
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